SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001418812-12-000036
Filing Date
2012-05-23
Accepted
2012-05-22 18:27:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT vrx13da4052212.txt SC 13D/A 36012
  Complete submission text file 0001418812-12-000036.txt   37713
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45947 | Film No.: 12862675
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133
Business Address 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 415-362-3700
VA Partners I, LLC (Filed by) CIK: 0001418812 (see all company filings)

IRS No.: 421745536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A